MRI Interventions, Inc. (NYSE:CLPT)’s stock price was up 16.5% on Monday . The stock traded as high as $5.23 and last traded at $5.23. Approximately 313,540 shares traded hands during trading, an increase of 524% from the average daily volume of 50,279 shares. The stock had previously closed at $4.49.

Several equities analysts recently issued reports on the company. Zacks Investment Research lowered MRI Interventions from a “hold” rating to a “sell” rating in a research report on Thursday, August 13th. B. Riley began coverage on shares of MRI Interventions in a report on Friday, July 17th. They issued a “buy” rating and a $8.00 price target for the company.

The firm’s fifty day moving average price is $4.23.

MRI Interventions (NYSE:CLPT) last posted its quarterly earnings data on Wednesday, August 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.05. The firm had revenue of $2.48 million for the quarter, compared to the consensus estimate of $1.88 million.

About MRI Interventions (NYSE:CLPT)

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for placing catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies.

Featured Article: Technical Analysis

Receive News & Ratings for MRI Interventions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MRI Interventions and related companies with MarketBeat.com's FREE daily email newsletter.